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Introduction {#sec1}
============

Despite advances in modern medicine, acute respiratory tract illnesses (ARIs) continue to be a global health concern. They are a major cause of morbidity and mortality, especially in infants and young children whose immune systems have not yet matured ([@bib14], [@bib55]), and are the most common reason for antibiotic use in children ([@bib1]). The upper airway is a reservoir for microbial communities including viruses, bacteria, and fungi, and these have implications for respiratory health and disease. However, current research into the etiology of ARIs focuses primarily on viruses, most notably respiratory syncytial virus (RSV) and human rhinoviruses (RV). The bacterial microbiome is increasingly recognized as playing an important role in the susceptibility and severity of ARIs, as well as non-communicable respiratory diseases such as asthma ([@bib45], [@bib12], [@bib32], [@bib51]). Infancy is a critical time when microbial colonization may influence an individual\'s future respiratory health or disease; indeed, epidemiological data show that repeated ARIs during early childhood are a major risk factor for wheeze and asthma that persist into adulthood ([@bib21]).

In recent years, we and others have described the nasopharyngeal microbiome (NPM) in early life (from birth to 1 or 2 years of age) ([@bib3], [@bib4], [@bib6], [@bib7], [@bib48], [@bib49]). These independent studies in different human populations have reported strikingly similar findings. Firstly, the NPM appears to be simple in structure, with distinct profiles dominated by a single bacterial operational taxonomic unit (OTU) or genus. A *Staphylococcus*-dominated profile can be observed in early infancy (from 1 week) but its prevalence decreases sharply over the first year, to be replaced by *Corynebacterium-*, *Alloiococcus* (*Dolosigranulum*)-, or *Moraxella*-dominated profiles, with transient incursions of *Streptococcus-* or *Haemophilus*-dominated profiles during ARIs. Secondly, NPM composition influences both microbiota stability and ARI risk and severity. One study of 60 infants from the Netherlands in the first two years of life reported a *Moraxella*-dominated or mixed *Corynebacterium*/*Dolosigranulum* profile at 1.5 months of age was associated with high NPM stability and low frequency of parent-reported ARIs in the subsequent period ([@bib3]). Our study of 234 infants from Australia in the first year of life also found that *Moraxella*-dominated and *Alloiococcus*-dominated profiles were more stable than others, but a *Moraxella*-dominated NPM at 2 months of age was associated with earlier onset of first ARI ([@bib48]). There were also common environmental correlates of the NPM that differed slightly across studies but included mode of delivery, infant feeding, season, crowding or exposure to other children, recent antibiotic use, and prior infections. Many of these studies, however, were limited to samples collected either during illness or during periods of health, and none have yet elucidated the dynamics of the NPM over the entire pre-school period.

Understanding patterns of airway microbial colonization and its association with ARIs and subsequent wheeze phenotypes is an important step toward the potential manipulation of the microbiome in treating or preventing acute or chronic respiratory disease. In this study, we performed a comprehensive characterization of the largest longitudinal collection of nasopharyngeal samples reported to date: more than 3,000 samples from 244 children collected during periods of respiratory health and acute illness over the first five years of life, as part of the prospective Childhood Asthma Study (CAS) ([@bib26], [@bib27], [@bib28], [@bib29], [@bib48]). We have previously reported an association between viral-associated lower respiratory infections (LRIs) in infancy, especially those accompanied by fever, and the development of persistent wheeze and asthma in later childhood at 5 and 10 years of age in this cohort, particularly for infants who developed allergic sensitization by age 2 ([@bib27], [@bib29]). In addition, we recently reported patterns of bacterial colonization in samples collected during the first year of life, and found that specific NPM profiles were associated with ARI symptom severity, independent of the effect of common respiratory viruses ([@bib48]). Here, we address several major research gaps: (1) we examine the relationships and longitudinal dynamics of NPM colonization within children, in health and during ARI episodes, across the first five years of life; (2) we investigate changes in the association of ARI symptoms with specific NPM taxa over the pre-school years; (3) we address whether the appearance of viral pathogens in the NPM is a harbinger of change in local bacterial populations, or vice versa; and (4) we investigate the relationship between NPM colonization, early allergic sensitization, and future persistent wheeze at 5 years of age.

Results {#sec2}
=======

We characterized the bacterial microbiome of 3,014 nasopharyngeal samples from 244 infants in their first five years of life, using 16S rRNA V4 region amplicon sequencing ([STAR Methods](#sec4){ref-type="sec"}).

Composition of Upper Airway Microbiota in the First Five Years of Life {#sec2.1}
----------------------------------------------------------------------

Across all samples, the dominant bacterial genera were *Moraxella* (40.1%), *Streptococcus* (13.3%), *Corynebacterium* (12.1%), *Alloiococcus* (11.1%), *Haemophilus* (8.6%), and *Staphylococcus* (4.2%). These made up 89% of all reads, consistent with previously reported results in this cohort for the first year of life ([@bib48]) ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}A). Each of the six major genera comprised multiple OTUs, although the majority were extremely rare. OTU distributions within *Moraxella*, *Alloiococcus*, and *Corynebacterium* were less diverse, with ≤5 OTUs making up ≥97% of all reads from each respective genus at any time period ([Figure S1](#mmc1){ref-type="supplementary-material"}B). OTU distributions within *Streptococcus*, *Haemophilus*, and *Staphylococcus* were more diverse, although still dominated by one or two OTUs ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The phylogenetic relationships between OTUs are indicated by the tree in [Figure 1](#fig1){ref-type="fig"}A, and details of their distribution and predicted species associations are discussed in [Figure S2](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.Figure 1Definition and Distribution of Microbiome Profile Groups(A) Heatmap shows relative abundances of 20 common operational taxonomic units (OTUs), aggregated values for other OTUs from the common genera, and aggregated values for all other rare OTUs within each sample. Tree to the left shows phylogenetic relationships between the sequenced V4 region of the 21 common OTU sequences. Dendrogram at the top indicates complete linkage clustering of Bray-Curtis distances between samples; colored bars indicate assignment to microbiome profile groups (MPGs) based on this clustering. Bar plot to the right shows the total abundance of each OTU or group of OTUs within the whole dataset; OTUs that dominate a common MPG are colored to match that MPG.(B) Distribution of MPGs within each time period, shown separately for healthy and acute respiratory illness (ARI) samples.See also [Figures S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}; [Table S2](#mmc1){ref-type="supplementary-material"}.

The distribution of the relative abundances of common OTUs across samples was highly structured ([Figure 1](#fig1){ref-type="fig"}A). We used hierarchical clustering to assign each sample to one of 15 microbiome profile groups (MPGs) ([Figure 1](#fig1){ref-type="fig"}). Most MPGs were dominated by one OTU, which was used to label each MPG ([Figure 1](#fig1){ref-type="fig"} and [Table S2](#mmc1){ref-type="supplementary-material"}). The exceptions were two "mixed" MPGs. "Mixed1" MPG contains samples (n = 327) in which the common OTUs were all at low abundance, and the vast majority of mixed1 samples (97%) were not dominated by any OTU; the rest were mostly ARI samples dominated by genera that likely represent known respiratory pathogens (*Mycoplasma*, *Bordetella*, *Neisseria*, *Pseudomonas*, *Prevotella*). "Mixed2" MPG (n = 51) represents a heterogeneous cluster with no distinct profile. The distribution of MPGs across ages is shown in [Figure 1](#fig1){ref-type="fig"}B.

Within-sample (alpha) diversity of the NPM increased with age in both healthy and ARI samples, with a noticeable increase after 2 years of age (generalized estimating equations linear regression of Shannon\'s diversity index versus age, adjusted for symptom status and gender: p = 1.1 × 10^−12^ after 2 years; [Figure 2](#fig2){ref-type="fig"} A). The increasing diversity after 2 years of age was due to both increasing number and increasing equitability (evenness) of the OTUs ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B), and this trend was observed within all MPGs ([Figure S3](#mmc1){ref-type="supplementary-material"}C).Figure 2Within-Sample Diversity Is Associated with Age and Acute Respiratory Illness Symptoms(A) Shannon diversity index (SDI) per sample over time, colored by symptom status as indicated (URI, upper respiratory illness; LRI, lower respiratory illness). Solid lines, loess smoothed curves; dashed lines, 95% confidence intervals.(B) SDI distributions within common MPGs. Asterisk indicates FDR adjusted p value of \<0.05 in GEE linear regression of SDI against healthy versus LRI, adjusted for age at collection (as in [Table S3](#mmc1){ref-type="supplementary-material"}).(C) Relative abundances of the dominant OTU within each MPG (as specified in [Table S1](#mmc1){ref-type="supplementary-material"}).See also [Figure S3](#mmc1){ref-type="supplementary-material"} and [Table S3](#mmc1){ref-type="supplementary-material"}.

Upper Airway Bacteria and Respiratory Infection {#sec2.2}
-----------------------------------------------

Consistent with our previously reported observations from the first year of life ([@bib48]), ARI was positively associated with MPGs dominated by *Haemophilus* (odds ratio \[OR\] 4.6, p = 1.9 × 10^−12^), *Streptococcus* (OR 3.9, p = 1.7 × 10^−17^), or *Moraxella* (OR 1.3, p = 1.8 × 10^−4^) ([Table S2](#mmc1){ref-type="supplementary-material"}). Within these MPGs, the relative abundance of the dominant OTU increased and the alpha diversity decreased with symptom severity (comparing healthy, with upper respiratory illness \[URI\], with LRI; [Figure 2](#fig2){ref-type="fig"}B and [Table S3](#mmc1){ref-type="supplementary-material"}). Thus overgrowth of these taxa accompanies spread of infection to the lower airways, although the direction of causation is not resolvable here.

At the OTU level, the relative abundances of 236 OTUs (present in \>10% of samples) were significantly different between ARI and healthy samples (absolute difference \>1.5-fold and false discovery rate \[FDR\] adjusted p value \<0.05). However, these associations were age dependent and appeared to shift following the increase in within-sample diversity observed from 2 years of age. Comparing the time periods before year 2 and on or after the second birthday, a total of 310 OTUs were found to be significantly associated with ARI in at least one interval (absolute difference \>1.5-fold and FDR adjusted p value \<0.025; [Figure S4](#mmc1){ref-type="supplementary-material"}A). The majority of *Moraxella*, *Haemophilus*, and *Streptococcus* OTUs were consistently positively associated with ARI in both time periods. *Staphylococcus*, *Corynebacterium*, and *Alloiococcus* OTUs were negatively associated with ARI in the first 2 years but these associations waned after 2 years, particularly for *Corynebacterium* and *Alloiococcus* ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Adjusting for the most common ARI-associated OTU, Moraxella 4398454 ([Figure S4](#mmc1){ref-type="supplementary-material"}B) resulted in little change to these associations, suggesting that Moraxella 4398454 and other OTUs contribute independently to ARI risk. Interestingly, we found two *Streptococcus* OTUs that were negatively associated with ARI (OTUs 4365744 and 509773, which show closest match to species *gordonnii* and *thermophilus*/*salivarius*/*vestibularis*, respectively; [Table S1](#mmc1){ref-type="supplementary-material"} and [Figure S2](#mmc1){ref-type="supplementary-material"}A). These were positively correlated with one other (SparCC correlation 0.09, p = 0.001), but negatively correlated with *Streptococcus* OTU 1059655 (SparCC correlation −0.09 and −0.1, respectively; p = 0.001), which has closest match to *pneumoniae*/*pseudopneumoniae*. The set of five MPGs dominated by ARI-associated *Moraxella*, *Streptococcus*, or *Haemophilus* OTUs are collectively termed here "illness-associated MPGs" ([Table S2](#mmc1){ref-type="supplementary-material"}). Among the rare OTUs, eight including from genera *Nitriliruptor* and *Bacilllus* were consistently health associated and often co-occurred together (at median relative abundance 9%) in samples belonging to the *Staphylococcus* MPG, while a further eight OTUs including from genera *Porphyromonas*, *Candidatus, Aquiluna*, *Clavibacter*, *Mycobacterium*, *Granulicatella*, and *Fusobacterium* were consistently ARI associated but generally of low abundance across all MPGs ([Figures S4](#mmc1){ref-type="supplementary-material"}C and S4D).

To more precisely estimate how these associations change with age, we performed time-varying analysis for eight characteristic OTUs using smoothing splines ANOVA ([STAR Methods](#sec4){ref-type="sec"}). The results showed that the strength of association of *Corynebacterium*, *Alloiococcus*, and *Staphylococcus* with healthy samples was greatest in the first 1--2 years; interestingly the association waned toward the null by 3 years of age for *Corynebacterium* and 4 years of age for *Staphylococcus*, but *Alloiococcus* changed direction and was significantly associated with ARI in the interval 2.8--3.9 years (mean difference 1.8-fold, p = 0.01) ([Figure 3](#fig3){ref-type="fig"} A). *Alloiococcus otitidis* in the ear canal has been implicated in otitis media (OM) ([@bib20], [@bib47]), along with *Streptococcus pneumoniae* and *Haemophilus influenzae* ([@bib33]). In this cohort, 11% of ARI episodes co-occurred with OM. *Streptococcus* OTU 1059655 abundance in the NPM during ARI was positively associated with concurrent OM from 18 months (mean difference 2.4-fold, p = 0.01), but *Alloiococcus* and *Haemophilus* showed no significant associations with OM. The *Alloiococcus*-illness association is further addressed below.Figure 3Time-Varying Associations of Bacterial Taxa with Acute Respiratory Illness Symptoms(A) Log~2~ fold change (solid lines) and 95% confidence intervals (dashed lines) comparing symptomatic versus healthy samples, estimated using smoothing splines ANOVA. Non-significant segments are colored gray.(B) Same as (A) but including further adjustment for *Moraxella* OTU 4398454 abundance (dark-green curve) and vice versa (dark-red curve).See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Co-occurrence of Bacteria and Viruses in the Upper Airways and Their Association with Respiratory Illness {#sec2.3}
---------------------------------------------------------------------------------------------------------

We calculated pairwise correlation networks between OTUs separately for samples collected before 2 years of age and on or after the second birthday; values for the eight most common OTUs are shown in [Figure 4](#fig4){ref-type="fig"} A. Illness-associated OTUs of *Moraxella*, *Haemophilus*, and *Streptococcus* formed a group that were all positively correlated with one another in both time periods, and negatively correlated with the health-associated *Streptococcus* OTU 509773 and *Staphylococcus* ([Figure 4](#fig4){ref-type="fig"}A). *Corynebacterium* and *Alloiococcus* were strongly correlated with one another in both periods (SparCC correlation = 0.68, p = 0.001). Surprisingly, the relationship between these OTUs and those in the illness-associated group ([Figure 4](#fig4){ref-type="fig"}A) was complex and changed over time, becoming significantly more positively correlated with age ([Figure 4](#fig4){ref-type="fig"}B). *Corynebacterium* and *Alloiococcus* were positively correlated with *Moraxella* throughout, with correlation strength increasing significantly over time ([Figure 4](#fig4){ref-type="fig"}A; Fisher\'s r to Z transformation comparing *Moraxella-Corynebacterium* and *Moraxella-Alloiococcus* correlations before and after 2 years: p = 9 × 10^−14^ and p = 7 × 10^−16^, respectively). *Corynebacterium* and *Alloiococcus* were negatively correlated with the illness-associated *Haemophilus* and *Streptococcus* OTUs in early years, but became positively correlated (*Streptococcus*) or uncorrelated (*Haemophilus*) in later samples ([Figures 4](#fig4){ref-type="fig"}A and 4B). We hypothesized that the increasing co-occurrence with *Moraxella* might explain the increasing association of *Alloiococcus* with ARI symptoms in later years. Indeed, adjusting for the abundance of *Moraxella* OTU 4398454 resulted in attenuation of the positive association of *Alloiococcus* with ARI after 2 years, but not the negative association with ARI prior to 2 years; whereas adjusting for the abundance of *Alloiococcus* has no effect on the association of *Moraxella* with ARI ([Figure 3](#fig3){ref-type="fig"}B). We interpret this to suggest that the apparent negative association between simple *Alloiococcus*-dominated communities before age 2 is likely due to the absence of pathogen-dominated communities rather than any actual protective effect of *Alloiococcus*. The negative association disappears in later years when bacterial diversity is greater and the presence of *Alloiococcus* is less likely to signal the absence of *Moraxella*, which itself is consistently positively associated with ARI. *Staphylococcus* was positively correlated with the health-associated *Streptococcus* 509773 (SparCC correlation = 0.22, p = 0.001) but negatively correlated with the illness-associated group as well as *Corynebacterium* and *Alloiococcus*.Figure 4Microbial Interaction Networks and Stability(A) Pairwise correlations among eight characteristic OTUs, calculated separately for samples collected up to and including 2 years of age (triangle of the heatmap below the diagonal), and samples collected after 2 years of age (triangle of the heatmap above the diagonal). Cell colors indicate correlation coefficients; non-significant correlations (p \> 0.001) are white. ^∗^Bonferroni-corrected p \< 0.05/28, testing for change in correlation before and after 2 years of age using Fisher\'s z test.(B) Correlations between *Alloiococcus* or *Corynebacterium* and *Moraxella* or *Streptococcus* or *Haemophilus* OTUs (bold gray box in A) over half-yearly time periods (filled circles, significant correlations, p = 0.001; empty circles, non-significant correlations, p \> 0.001).(C) Transitions between microbiome profile groups (MPGs) for consecutive pairs of healthy samples collected from the same individuals 6--12 months apart. OTU key: *Haemophilus*: A = 240051, B = 4469627, C = 956702; Moraxellaceae: A = 1057260, B = 854899; *Corynebacterium*: A = 4474764, B = 1049188, C = 4376867.(D) Proportion of healthy samples collected at each time point, for which the same MPG was detected in the next healthy sample from each individual. Colors indicate the specific MPGs involved, colored as in (C).See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Table S4](#mmc1){ref-type="supplementary-material"}.

We tested for common human respiratory viruses in all samples from the first three years of life; viruses were frequently detected in ARI samples (83% and 81% among URI and LRI, respectively). Interestingly, the same viruses were also detected among 34% of healthy samples, which had been collected after at least 1 month without ARI symptoms. The presence of virus was significantly associated with illness-associated MPGs (compared with health-associated MPGs) irrespective of symptom status (OR 2.4, p = 1.1 × 10^−6^ in healthy samples; OR 1.9, p = 1.0 × 10^−3^ in ARI samples using Fisher\'s exact test; [Figure S5](#mmc1){ref-type="supplementary-material"}), suggesting either mutualism, or synergistic effects on symptomatology, between these specific bacterial communities and common respiratory viruses. However, *Streptococcus*, *Moraxella*, and *Haemophilus* MPGs were also independently associated with ARI symptoms among samples in which no respiratory viruses were detected, or when adjusting for the presence of respiratory viruses or of the specific viruses, RSV or RV ([Figures 5](#fig5){ref-type="fig"}A and 5B). This suggests that either these bacteria contribute directly to illness, in the absence of known respiratory viral triggers, which is not unexpected given we predict they are dominated by known respiratory pathogens *S*. *pneumoniae*, *Moraxella catarrhalis*, and *H*. *influenzae*; or there is another unknown trigger (e.g., a novel virus) that promotes the overgrowth of these bacteria.Figure 5NPM Associations with Symptoms of Acute Respiratory Illness and Wheeze(A) Frequency of symptoms (URI, upper respiratory illness; LRI, lower respiratory illness) among samples stratified by the presence or absence (+/−) of known respiratory viruses and presence or absence (+/−) of bacterial communities assigned to *Moraxella*, *Streptococcus*, or *Haemophilus* microbiome profile groups (MPGs).(B) Association of acute respiratory illness (ARI) symptoms with specific MPGs, stratified by the presence or absence (+/−) of common respiratory viruses (RV, rhinovirus; RSV, respiratory syncytial virus; Vir, any virus). Odds ratios (OR) and 95% confidence intervals were estimated using generalized estimating equations with unstructured correlation and robust standard errors, adjusting for age, gender, and season.(C) Proportion of healthy samples assigned to *Moraxella*, *Streptococcus*, or *Haemophilus* MPGs, stratified by time relative to a recorded LRI episode. SE bars are given for the *Moraxella* MPG. We regressed assignment to *Moraxella* MPG against time to LRI (separate models for each time category versus all other healthy samples) (^∗^p \< 0.05).(D) Frequency of pre-school wheeze phenotypes (y axis), stratified by frequency of *Moraxella*, *Streptococcus*, or *Haemophilus* MPGs among healthy samples collected from 6 months to 2 years of age (x axis, in tertiles). Data are shown separately for 73 children who were allergic sensitized by 2 years of age, and 64 who were not.See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}.

Stability of the Upper Airway Microbiota within Individuals {#sec2.4}
-----------------------------------------------------------

The NPM is a complex ecosystem that is inherently dynamic as it is continually being shaped by multiple factors, including responses to environmental perturbation and disease status of the host. We therefore examined the effects of external factors, including ARI and antibiotic exposure, on intra-individual NPM dynamics.

We first considered consecutive healthy samples from each individual, excluding sample pairs collected more than 1 year apart. Overall, the probability of the next consecutive healthy sample sharing the same (non-mixed) MPG as the current sample (i.e., a stable transition) was greater than expected by chance (31% versus 18% for samples collected \<6 months apart, binomial test p = 2.3 × 10^−7^; 23% versus 18% for samples collected 6--12 months apart, p = 0.011), indicating some degree of stability of the microbial communities within individuals over time. This stable transition probability was highest for the *Moraxella* (45%) and *Alloiococcus*-*Corynebacterium* (32%) MPGs, which were the most common states for healthy NPM samples ([Figure 4](#fig4){ref-type="fig"}C). Where a sample was assigned to the mixed1 MPG, the probability of the next sample also being designated mixed1 was high (30%). However, the composition of such samples can vary widely, and Bray-Curtis distances between consecutive mixed1 MPG samples were close to the distances between distinct MPGs ([Figure S6](#mmc1){ref-type="supplementary-material"}), indicating that the majority of consecutive pairs assigned to mixed1 MPG represent significant shifts in NPM composition rather than stable transitions. The probability of a stable transition to the next time point was significantly lower at 2 months of age than at 6-, 12-, 18-, or 24-month time points ([Figure 4](#fig4){ref-type="fig"}D; 20% versus 31%; Fisher\'s exact test, p = 0.03), consistent with the observation of a distinct NPM profile at 2 months ([Figure 1](#fig1){ref-type="fig"}B). Transition stability declined after 2 years, and an increasing proportion of transitions involved consecutive samples assigned to the mixed1 MPG ([Figure 4](#fig4){ref-type="fig"}D), consistent with the observed increase in diversity after age 2 ([Figure 2](#fig2){ref-type="fig"}A). The frequency of persistence of the *Staphylococcus* MPG dropped after 6 months and increased again in the fourth year, consistent with prior observations that maternally transferred *Staphylococcus aureus* can be detected in infants, but stable colonization is not established until the pre-school years ([@bib9], [@bib24], [@bib43]). Taken together, these results show that the NPM is highly variable in early childhood. Stability of health-associated MPGs was significantly disrupted by the occurrence of LRI during the sampling interval (p = 0.00042); however, antibiotic use did not significantly alter the probability of stable transitions (p = 0.72; [Table S4](#mmc1){ref-type="supplementary-material"}).

Association of Upper Airway Microbiota with Lower Respiratory Illness and Subsequent Wheeze {#sec2.5}
-------------------------------------------------------------------------------------------

LRI was significantly positively associated with *Moraxella*, *Streptococcus*, and *Haemophilus* MPGs, and negatively associated with *Corynebacterium*, *Alloiococcus-Corynebacterium*, and *Staphylococcus* MPGs, especially among samples collected up to 2 years of age ([Table S5](#mmc1){ref-type="supplementary-material"}). This is consistent with our previously reported findings from the first year of life ([@bib48]); but here we had sufficient numbers of pre- and post-LRI asymptomatic samples to also investigate whether LRIs were associated with prior colonization by the illness-associated *Moraxella*, *Streptococcus*, and *Haemophilus* MPGs, and how long these MPGs persisted after an incident LRI. Healthy samples collected 1--2 weeks prior to an LRI were not enriched for viruses (∼30% frequency of virus detection, versus 34% across all healthy samples and ∼80% during LRI), but were significantly enriched for the *Moraxella* MPG (GEE logistic regression of assignment to *Moraxella* MPG on time to LRI, 1--2 weeks compared with all other healthy samples and adjusted for time post LRI, gender, age, season, recent antibiotics: OR 6.2 \[95% confidence interval 1.4--28\], p = 0.017; further adjusted for viruses: OR 5.9 \[1.3--26\], p = 0.019) ([Figure 5](#fig5){ref-type="fig"}C), as well as *Moraxella* abundance (GEE linear regression of log *Moraxella* OTU abundance, p = 0.025; further adjusted for viruses: p = 0.04) ([STAR Methods](#sec4){ref-type="sec"}). There were no significant differences in proportions of *Streptococcus* or *Haemophilus* MPGs nor *Streptococcus* or *Haemophilus* abundance; however, these MPGs were rare (∼7%) in healthy samples. We were unable to assess short-term changes in the NPM following LRI, as our criteria for healthy sample collection required the absence of ARI symptoms for at least 4 weeks; however, the *Moraxella* MPG exhibited declining frequency with increasing time post LRI, and remained enriched until 6 months post LRI ([Figure 5](#fig5){ref-type="fig"}C). Interestingly, there was no evidence of a difference in MPG distribution before or after URI ([Figure S7](#mmc1){ref-type="supplementary-material"}).

We have previously shown in this cohort that the risk of chronic wheeze at 5 years of age is significantly associated with the number of LRIs in the first year of life. This was especially the case for the number of febrile LRIs among children with allergic sensitization by age 2 ([@bib27], [@bib29], [@bib48]). Here, we investigated whether presence of the illness-associated *Moraxella*, *Streptococcus*, and *Haemophilus* MPGs during the first four years of life was predictive of LRI intensity during the same period, and/or wheeze at age 5. For each child, we calculated the combined frequency of these MPGs among healthy NPM samples over different time periods ([STAR Methods](#sec4){ref-type="sec"}). Among children with early allergic sensitization, frequent ARI-associated MPGs (≥50% of healthy NPM samples) during the first two years of life was significantly positively associated with the number of LRIs experienced in the same period ([Table 1](#tbl1){ref-type="table"} ). Importantly, among these early-sensitized children, the frequency of illness-associated MPGs in the first two years of life was independently associated with chronic wheeze at 5 years of age ([Figure 5](#fig5){ref-type="fig"}D), even after adjusting for LRI frequency and type ([Table 2](#tbl2){ref-type="table"} ). Notably, among non-sensitized children, the frequency of illness-associated MPGs was not associated with chronic wheeze at 5 years but was significantly positively associated with the transient wheeze phenotype (defined as any wheeze in the first three years of life but no wheeze in the fifth year) ([Figure 5](#fig5){ref-type="fig"}D and [Table 2](#tbl2){ref-type="table"}). We also note that LRI frequency in years 3--4 was associated with wheeze at age 5 regardless of sensitization status, which we attribute to recent respiratory inflammation being more directly linked to current wheeze ([Table 2](#tbl2){ref-type="table"}). There were no significant associations between sensitization status and LRI severity, i.e., the raw frequency or relative proportion of severe (febrile or wheezy) LRIs (Kruskal test, p \> 0.05 for all time points).Table 1Associations between Proportion of Illness-Associated MPGs in Healthy Samples and LRI FrequencyOutcomeEarly Allergic SensitizationAll Other ChildrenMPGs 6m--2y (n = 74)MPGs 2.5y--4y (n = 83)MPGs 6m--2y (n = 65)MPGs 2.5y--4y (n = 65)\# LRI at ages 0 to 11.6 (1--2.6), p = 0.0431.1 (0.83--1.5), p = 0.491.5 (0.95--2.3), p = 0.0811.1 (0.79--1.5), p = 0.57\# LRI at ages 1 to 21.5 (1--2.2), p = 0.0361.1 (0.81--1.5), p = 0.61.4 (0.91--2.1), p = 0.121.2 (0.81--1.7), p = 0.38\# LRI at ages 2 to 41.4 (1--1.9), p = 0.0321.1 (0.79--1.4), p = 0.720.99 (0.79--1.2), p = 0.931.1 (0.87--1.3), p = 0.47\# Febrile LRI at ages 0 to 12.5 (1--6.3), p = 0.0491.2 (0.63--2.4), p = 0.532.2 (0.77--6.1), p = 0.140.84 (0.36--2), p = 0.69\# Febrile LRI at ages 1 to 21.8 (0.85--3.6), p = 0.130.59 (0.3--1.2), p = 0.132.4 (0.65--8.9), p = 0.191.8 (0.71--4.6), p = 0.21\# Febrile LRI at ages 2 to 41.8 (0.88--3.9), p = 0.110.99 (0.5--2), p = 0.981.6 (0.74--3.5), p = 0.231.4 (0.76--2.5), p = 0.3[^3]Table 2Prediction of Subsequent Wheeze Phenotypes Based on Proportion of Illness-Associated MPGs among Healthy Samples during the First Two Years of LifeData SubsetModel (Y ∼ MPG + X)Predictor = MPGPredictor = XYXOR (95% CI)pOR (95% CI)pEarly-sensitized children (n = 73)wheeze at 5y (n = 26)none2.5 (1.3--4.6)0.0054NA\# LRI (year 1)2.2 (1.1--4.2)0.0181.5 (0.94--2.5)0.085\# LRI (year 2)2.3 (1.2--4.3)0.0131.3 (0.89--1.8)0.18\# LRI (years 3--4)2 (0.94--4.2)0.0732.4 (1.5--3.9)0.00059\# febrile LRI (year 1)2.1 (1.1--4.1)0.0262.9 (1.1--7.5)0.032transient wheeze (n = 19)none0.5 (0.23--1.1)0.074NA\# LRI (year 1)0.44 (0.19--0.99)0.0471.4 (0.8--2.3)0.26\# LRI (year 2)0.41 (0.17--0.96)0.0391.3 (0.93--1.9)0.12\# LRI (year 3--4)0.54 (0.25--1.2),0.120.86 (0.6--1.2)0.39\# febrile LRI (year 1)0.48 (0.22--1.1)0.0681.3 (0.45--3.5)0.67All other children (n = 64)wheeze at 5y (n = 15)none0.94 (0.5--1.8)0.86NA\# LRI (year 1)0.93 (0.49--1.8)0.831.1 (0.73--1.5)0.74\# LRI (year 2)0.91 (0.46--1.8)0.781.5 (0.99--2.2)0.059\# LRI (years 3--4)1.2 (0.49--3)0.663.8 (1.8--8.3)0.00062\# febrile LRI (year 1)0.94 (0.49--1.8)0.841.2 (0.42--3.2)0.76transient wheeze (n = 22)none2.2 (1.2--4.1)0.014NA\# LRI (year 1)2.2 (1.1--4.2)0.0221.5 (1--2.2)0.027\# LRI (year 2)2.2 (1.2--4.1)0.0141.1 (0.75--1.6)0.62\# LRI (years 3--4)2.3 (1.2--4.6)0.0140.53 (0.3--0.92)0.024\# febrile LRI (year 1)2.2 (1.1--4.3)0.0183.4 (1.2--9.5)0.018[^4]

Discussion {#sec3}
==========

This study presents a comprehensive, longitudinal characterization of the upper airway microbiome in a cohort followed from birth to 5 years of age, and its association with episodes of ARI, allergic sensitization, and subsequent wheezing phenotypes. We found the NPM from birth to 5 years of age remains dominated by six common genera ([Figure 1](#fig1){ref-type="fig"}) and has yet to converge to an adult-like NPM, which is characterized by much greater alpha diversity, lack of *Moraxella* and *Corynebacterium*, and much lower biomass ([@bib44]). This is in contrast to the oropharynx ([@bib44]) or the gut microbiome, which matures to an adult-like state by 3 years of age ([@bib53]). The NPM is composed of robust internally homogeneous MPGs, consistent with existing literature pointing to discrete microbial compositions in the nasopharynx during early childhood ([@bib3], [@bib4], [@bib6], [@bib7], [@bib48], [@bib49]). Consistent with previous observations ([@bib3]), we found a constant level of NPM diversity over the first two years of life, followed by a period of increasing diversity, in terms of both number and equitability of OTUs, for at least 3 years ([Figures 2](#fig2){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}). This increasing diversity coincided with a change in the relationship between the NPM and respiratory disease, whereby negative associations between MPGs and ARI became attenuated (as in the case of *Corynebacterium*) or changed direction to become positively associated with ARI (*Alloiococcus*) ([Figure 3](#fig3){ref-type="fig"}A). In the latter case, this appears to be driven by an increasing alliance with *Moraxella* ([Figures 3](#fig3){ref-type="fig"}B and [4](#fig4){ref-type="fig"}), which itself was ARI associated. *Moraxella* establishes biofilms that enhance the co-survival of pathogens such as *S. pneumoniae* and *H. influenzae* ([@bib37], [@bib38]). It is not yet clear whether the negative associations of certain taxa with ARI denote active protective effects, or simply the lack of pathogenic drivers of symptoms; however, there is some evidence from murine models that pre-exposure to *Corynebacterium* can provide some resistance against RSV infection ([@bib25]).

Our longitudinal data show the NPM can be highly dynamic within individuals. However, there was some stability even between samples collected 6 or 12 months apart ([Figures 4](#fig4){ref-type="fig"}C and 4D), especially for the MPGs dominated by *Moraxella* or *Alloiococcus* and *Corynebacterium*, which appear to be stable colonizers of the nasopharynx of children. Notably, stability of the *Alloiococcus-Corynebacterium* MPG was significantly reduced by LRI episodes, which are typically associated with an influx and/or overgrowth of *Moraxella*, *Streptococcus*, or *Haemophilus* that can presumably destabilize the bacterial community. This is consistent with a recent study that reported reduced stability of the NPM during infancy among children who experienced more than two ARIs in the first year of life ([@bib7]). Ultimately, more comprehensive description of natural NPM dynamics, including detailed assessment of resilience to exogenous agents, will require higher-resolution sampling (weekly or daily) and would also benefit from larger cohorts.

Throughout the first five years of life, NPM samples collected during ARIs showed a greater abundance of, and were more commonly dominated by, specific *Streptococcus*, *Moraxella*, and *Haemophilus* OTUs ([Figures 1](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}; [Table S2](#mmc1){ref-type="supplementary-material"}), consistent with expectations regarding common respiratory pathogens *S*. *pneumoniae*, *M*. *catarrhalis*, and *H*. *influenzae* to which these OTU sequences were most closely related ([Table S1](#mmc1){ref-type="supplementary-material"}). The relative abundances of these OTUs were significantly correlated with one another ([Figure 4](#fig4){ref-type="fig"}A); we hypothesize that this is related to the protection provided by the *Moraxella* biofilm ([@bib46]), which can release outer membrane surface proteins that protect other bacteria from complement-dependent killing. Other groups have previously reported reduced upper airway microbial diversity during or prior to ARIs ([@bib16], [@bib42], [@bib54]); our data support this, in terms of both enrichment of a small number of community profiles (MPGs) during ARI, and a higher abundance of ARI-associated OTUs and lower alpha diversity within these MPGs compared with that observed in the absence of ARI symptoms ([Figures 2](#fig2){ref-type="fig"}B and [S3](#mmc1){ref-type="supplementary-material"}; [Tables S2](#mmc1){ref-type="supplementary-material"} and [S3](#mmc1){ref-type="supplementary-material"}). We therefore propose that overgrowth of these particular taxa may tip the balance toward respiratory symptomatology, either by direct action as invasive pathogens or via indirect dysregulation of the local immunological milieu. Such dysregulation may increase the likelihood of a primary viral infection of the nasopharyngeal mucosa, or subsequent spread of infection to the lower airways, as suggested in our earlier study on this cohort during infancy ([@bib48]). This is further supported by the increased prevalence of *Moraxella* in asymptomatic samples collected 1--2 weeks before an LRI ([Figure 5](#fig5){ref-type="fig"}C). Most LRIs (\>80%) had a known respiratory virus present, and this is likely the trigger for acute symptoms. However, the lack of enrichment for viruses, but enrichment for *Moraxella*, in the 1--2 weeks preceding LRI suggests that having the bacteria present when the virus is encountered increases the likelihood of severe respiratory illness. While our study had insufficient power to detect similar effects for *Streptococcus* and *Haemophilus*, due to low colonization frequency in our cohort, there is a large body of evidence accumulating around specific mechanisms of interaction between human respiratory viruses (mainly RV, RSV, and influenza) and *S. pneumoniae*, *H. influenzae*, and *M. catarrhalis*; including both viral promotion of bacterial colonization and outgrowth (for which we see evidence in the form of increased abundance of pathogenic genera in ARIs), and bacterial promotion of viral receptor expression on host cells ([@bib7], [@bib8]). While the present study cannot address specific mechanisms it provides evidence for interactions in both directions, and demonstrates that bacterial colonization influences subsequent ARI throughout infancy and early childhood.

Finally, we found a significant relationship between asymptomatic colonization of the upper airways by certain MPGs in the first two years of life and later wheezing phenotypes, conditional on early allergic sensitization ([Figure 5](#fig5){ref-type="fig"}D and [Table 2](#tbl2){ref-type="table"}). This builds on the results described in our previous study looking only at the first year of life, where we found that early-life colonization with *Streptococcus* was a risk factor for later childhood wheeze that is exacerbated by early allergic sensitization ([@bib48]). In the present study, we identified that in early-sensitized children, asymptomatic colonization of the upper airways by all illness-associated MPGs (*Streptococcus*, *Haemophilus*, and *Moraxella*) increased the risk of chronic wheeze at 5 years of age, while in children who had not developed early allergic sensitization, it was associated only with transient early wheeze, which resolved by the fourth year of life. Furthermore, in early-sensitized children the frequency of asymptomatic colonization with illness-associated MPGs was also associated with recurrence of LRIs, particularly those accompanied by fever, throughout the first four years of life ([Table 1](#tbl1){ref-type="table"}). Notably, however, while frequency of LRI is associated with 5-year chronic wheeze ([@bib27], [@bib48]), the effect of bacterial colonization on 5-year wheeze remained after adjusting for LRI ([Table 2](#tbl2){ref-type="table"}). It has been suggested that the pathogenic bacterial species *S*. *pneumoniae*, *H*. *influenzae*, and *M*. *catarrhalis* induce local immunoinflammatory responses in the upper airways of neonates, which in the case of *M*. *catarrhalis* and *H*. *influenzae* include upregulation of a mix of Th1/Th2/Th17 cytokines ([@bib15]). However, how these immune responses differ between sensitized and non-sensitized children is incompletely understood. We have suggested, based on previous studies in this and other asthma-risk cohorts ([@bib21]), that the increased severity of these episodes in children with allergic sensitization is due in part to interactions between infection-associated type 1 interferon-mediated and allergy-associated Th2-mediated inflammatory pathways, which compromise their capacity to efficiently clear respiratory pathogens, thus worsening ensuing airway inflammation and resultant immunopathology. Conversely, host immune defense mechanisms in those who are non-sensitized are not compromised by these interactions, and they accordingly experience only transient illnesses. This effect may not be confined to bacterial microbiota; others have described causal relationships and synergistic interaction between allergic sensitization and viral infection, particularly rhinovirus ([@bib23], [@bib41]).

In conclusion, this study suggests that the microbiota of the upper airways is an important determinant of the susceptibility, frequency, and severity of ARI in early childhood. In conjunction with early allergic sensitization, the dominating presence of illness-associated MPGs (*Streptococcus*, *Haemophilus*, and *Moraxella*) in the upper airways is a significant risk factor for persistent wheeze in school-age children, which is the hallmark of the asthma phenotype. This observation is of potential importance in relation to early detection and prevention of asthma. In particular, sensitized children in this cohort already showed elevated levels of allergen-specific immunoglobulin E production from 6 months of age ([@bib22]), suggesting that a high-risk group could be identified in infancy. Airway microbiome monitoring and potential modification might be beneficial for this high-risk group in reducing the risk of LRI, the repeated occurrence of which is closely linked to asthma development.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Biological Samples**Paediatric nasopharyngeal samplesPrivate clinics in Perth, Western AustraliaN/A**Critical Commercial Assays**Illumina MiSeq SystemIlluminaRRID: SCR_016379**Deposited Data**Raw sequence data from 16S profilingThis studySRP056779**Oligonucleotides**5′-AATGATACGGCGACCACCGAGATCTACACTA\
TGGTAATTGTGTGCCAGC MGCCGCGGTAA-3′515F 16S V4 forward primer([@bib11])5′-CAAGCAGAAGACGGCATACGAGATNNNNNNNNNN\
NNAGTCAGTCAGCCGGACTACHVGGGTWTCTAAT-3′806R 16S V4 reverse primer([@bib11])**Software and Algorithms**Blast+([@bib10])<https://blast.ncbi.nlm.nih.gov/Blast.cgi>fastspar([@bib52])<https://github.com/scwatts/fastspar>metagenomeSeq([@bib35])<https://github.com/HCBravoLab/metagenomeSeq>Picrust v1.0([@bib30])<https://picrust.github.io/picrust/>QIIME Version 1.7([@bib11])[qiime.org](http://qiime.org){#intref0030}Seaview v4.6.2([@bib18])<http://doua.prabi.fr/software/seaview>SparCC([@bib17])<https://bitbucket.org/yonatanf/sparcc>The R project for statistical computing([@bib40])<https://www.r-project.org>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Michael Inouye (<minouye@baker.edu.au>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Sample and Data Collection {#sec4.3.1}

This study is part of the Childhood Asthma Study (CAS) -- a prospective community-based cohort of 244 children (57% male) at high risk of allergic sensitization (at least one parent with a doctor diagnosed history of asthma, hay fever or eczema) who were followed prenatally until five years of age with the goal of identifying risk factors for allergic diseases, as previously described ([@bib26], [@bib27], [@bib29], [@bib48]). Children were recruited between 1996 and 1998, before the introduction of the pneumococcal vaccine in Western Australia in 2005. Healthy nasopharyngeal (NP) samples were collected at planned half-yearly visits (first sample from about 2 months of age, subsequently at 6 months, 1 year, and so on), in the absence of any symptoms of acute respiratory illness (ARI) for at least 4 weeks. In addition, parents were to contact a study clinician at the onset of any ARI symptoms, at which point a study nurse visited the family within 48 hours to collect a NP sample from the child and interview the parents on the symptoms and medications used in relation to the illness. ARIs were classified as a lower respiratory illness (LRI) if accompanied by wheeze or rattly chest; or an upper respiratory illness (URI) otherwise. A total of 1943 healthy samples, 2579 URI samples, and 1056 LRI NP samples were collected and divided into aliquots that were cryofrozen for later analysis. Healthy samples that did not fulfil the criterion of \>4 weeks after an illness episode were excluded. Parents kept a daily record of any medication used, from which antibiotic exposure information was extracted, and completed yearly questionnaires during face-to-face interviews. Blood samples were collected from each child at 6 months, 1, 2, 3, 4 and 5 years of age, and positive sensitization status at each timepoint was defined as serum IgE levels \> 0.35 kU/L to house dust mite, cat epithelium and dander, peanut, foodmix, couch grass, rye grass, mould mix, or infant phadiatop (details of which were described in ([@bib22])). All models included gender as a covariate.

The study design is a large prospective birth cohort, the gold standard for observational research. There were no interventions thus randomization and blinding were not relevant. Individuals were representative of the local population (Perth, Australia). Replication of this study is not currently feasible as this would require a separate prospective birth cohort with similar environment, sampling, sequencing, clinical follow-up, etc. Future studies are anticipated to address this.

Approval for the study was obtained from the ethics committee of King Edward Memorial and Princess Margaret Hospitals in Western Australia. Fully informed written consent was obtained from the parents for the use of stored samples for research projects.

Method Details {#sec4.4}
--------------

### Bacterial 16S Profiling {#sec4.4.1}

One aliquot from each of 1331 healthy, 996 URI and 1055 LRI samples were prepared for bacterial 16S rRNA amplicon sequencing. Total DNA was extracted using a method combining homogenization and chemical lysis of cells. Extractions were performed in biosafety cabinets that were UV-sterilised, including all plastic-ware, for 30 min prior to the procedure. The samples were thawed from -80°C storage, transferred into 1.5 mL sterile screw-capped tubes and briefly micro-centrifuged. The saline storage buffer was removed and pellets were resuspended in 400 μL of lysis solution supplied with the Wizard SV Genomic DNA System (Promega, Victoria, Australia). Samples were mixed vigorously by pipetting and then transferred into a labelled Lysing Matrix B tube (MP Biomedicals, New South Wales, Australia). Suspensions were homogenized using a FastPrep-24 homogenizer for 40 s at 6.5 m/s. Following micro-centrifugation, homogenates were transferred into a 1.5 mL screw-capped tube. A further 200 μL of lysis solution was added into each lysing matrix tube and vortexed to wash off any residual homogenate, then transferred to the respective homogenate tube to retain the original lysis volume. Homogenates were then treated with nuclei lysis buffer/RNase A and DNA extraction was carried out using the Wizard SV Genomic DNA System as per manufacturer's instructions. Purified DNA was eluted in 100 μL of pre-warmed sterile low 1 X TE (Fisher Biotec, WA, Australia), aliquoted and stored at -80°C.

Amplicons were prepared for MiSeq sequencing using primers (prepared by Integrated DNA Technologies, Iowa, USA) spanning the V4 region of the 16S rRNA gene and containing barcoded reverse primers as published by Caporaso et al. ([@bib11]). The forward universal primer included the 5′ Illumina adapter sequence, forward primer pad, linker and the 515F 16S rRNA sequence: 5′-AATGATACGGCGACCACCGAGATCTACACTATGGTAATTGTGTGCCAGC MGCCGCGGTAA-3′. The reverse primer included the 3′ Illumina adapter sequence, a 12-mer Golay barcode (denoted as N), reverse primer pad, linker and the 806R 16S rRNA sequence: 5′-CAAGCAGAAGACGGCATACGAGATNNNNNNNNNNNNAGTCAGTCAGCCGGACTACHVGGGTWTCTAAT-3′. All laboratory equipment used was wiped with DNA Away (MBP, Mexico) before conducting each PCR procedure. Master mixes were prepared in a UV-treated PCR chamber before they were dispensed into 96-well plates using a Multiprobe II liquid handling system (Perkin Elmer, Victoria, Australia), followed by addition of samples and controls using the robot. Amplification of each sample was performed in quadruplicate to obtain enough amplicon for sequencing. To each plate, a positive control (gDNA from *S*. *enterica* strain LT2, a bacterium not normally associated with the respiratory system (ATCC\#700720D-5, USA)) and water and TE negative controls (obtained from each extraction procedure) were included and assessed for amplification by agarose gel electrophoresis. All controls were as expected: *S*. *enterica* controls were positive and the water and TE negative controls were negative. Positive control samples were not analysed further, while the negative controls were prepared for sequencing in the same way as samples.

Due to the high throughput nature of this study, we did not quantify and normalize sample DNA that was added into each PCR reaction, rather a fixed volume (4 μL) of DNA template was used per well. Amplification was conducted on a GeneAmp 9700 PCR System (Perkin Elmer) using the following conditions: an initial 94°C denaturation step for 2 min, followed by 30 cycles of 94°C denaturation for 30 s, 58°C annealing for 30 s and 72°C extension for 1 min.

Quadruplicate sample amplicons were combined into a single well on the PCR reaction plate, then transferred to a fresh round-bottom polystyrene plate where they were purified using Agencourt AMPure XP beads as directed by the manufacturer, with slight modifications (Beckman Coulter, USA). Purified amplicons were eluted in 25 μL sterile low 1 X TE buffer (Fisher Biotec). Quantitation of amplicon was performed using the Quant-iT PicoGreen dsDNA quantitation kit (Life Technologies, Victoria, Australia) and fluorescence was determined on a Wallac Victor^3^ Multilabel counter (Perkin Elmer). PCR samples were equalized to 2 nM concentration (a neat aliquot was used where a sample fell below this concentration) and pools of 48, 60 or 96 barcoded samples were generated and sent for sequencing.

Primer adaptors were removed from library pools using a 0.8x ratio of Agencourt AMPure XP beads (Beckman Coulter, USA). Library quantitation was determined by the high sensitivity Qubit kit (Life Technologies, USA) whilst library quality and average size distribution was assessed by the Bioanalyser (Agilent Technologies, USA) high sensitivity kit. Library pools were diluted to 2nM followed by NaOH denaturation as per manufacter's instructions (Illumina Inc., USA). Sequencing primers read 1: 5'- TATGGTAATTGTGTGCCAGCMGCCGCGGTAA -3', read 2: 5'-AGTCAGTCAGCCGGACTACHVGGGTWTCTAAT-3' and index: 5'-ATTAGAWACCCBDGTAGTCCGGCTGACTGACT-3' (Sigma, Australia) were spiked into the MiSeq Cartridge at a final concentration of 0.5μM. Denatured libraries were loaded at 6.5pM with a 5% PhiX spike for diversity and sequencing control, onto a v2 300 cycle cartridge for sequencing on the Illumina MiSeq.

Paired end reads were merged using Flash version 1.2.7 ([@bib31]) with read length 151 base pairs (bp) and expected fragment length 253 bp. The merged reads were quality filtered as follows: ≤3 low-quality bp (Phred quality score \< 3) allowed before truncating a read, ≥189 consecutive high-quality bp, sequences with any N characters were discarded. Reads were clustered into operational taxonomic units (OTUs) using the closed reference OTU picking method in QIIME v1.7 using the Greengenes 99% reference database version 13_05. Mean of 1% of reads per sample had no match to the Greengenes database and were excluded from further analysis (except for alpha diversity calculations, as described below). Negative control samples had a median of \>1500 (taxonomy-assigned) reads (interquartile rage 900 -- 2300), while NP samples had a median of \>147K reads (IQR 45K -- 230K). We therefore removed 142 NP samples with \<3000 taxonomy-assigned reads. A total of 3014 samples were left for further analysis, including 1018 healthy samples (median 5 samples per child, IQR 3-6), 964 samples from upper respiratory illnesses (URIs; median 4 samples per child, IQR 2-6), and 1,032 samples from lower respiratory illnesses (LRIs; median 4 samples per child, IQR 2-7).

Because entries in the Greengenes database may be identical in the V4 subregion that we sequenced, it is possible for identical read sequences to be assigned to different Greengenes OTUs. We therefore merged counts for OTUs that were identical in the sequenced V4 region (identified by extracting the sequence between the forward and reverse primer sequences), as shown in [Figure S2](#mmc1){ref-type="supplementary-material"}. Read counts were corrected for OTU-specific copy number using Picrust v1.0 ([@bib30]) using the pre-computed copy number estimates for Greengenes OTUs version 13_05; and relative abundances were calculated by normalising to the total taxonomy-assigned reads for each sample. Phylogenetic analyses were conducted by BLAST ([@bib10]) searching the NCBI 16S rRNA database using representative V4 region sequences from the common taxa ([Figure S1](#mmc1){ref-type="supplementary-material"}B) to identify similar sequences. For each genus, the sequences were aligned using Muscle ([@bib13]) and a maximum-likelihood tree constructed using PhyML ([@bib19]) and visualized in Seaview ([@bib18]) ([Figure S2](#mmc1){ref-type="supplementary-material"}); these were used to identify the closest known species for each common OTU ([Table S2](#mmc1){ref-type="supplementary-material"}).

### Virus Detection {#sec4.4.2}

A second aliquot from 736 healthy, 583 URI and 789 LRI samples from the first three years (72%, 76% and 60% of all healthy, URI and LRI samples, respectively for which we had 16S profiles), were prepared for viral detection via reverse transcriptase polymerase chain reactions (PCR). Target organisms were: human rhinoviruses (RV); other picornaviruses (coxsackie, echo and enteroviruses); coronaviruses 229E and OC43; respiratory syncytial virus (RSV); influenza A and B; parainfluenzaviruses 1-3; adenoviruses and human metapneumovirus (HMPV). Primers, probes and PCR assay conditions have been previously described ([@bib5], [@bib26], [@bib27]).

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

### Clustering into Microbiome Profile Groups {#sec4.5.1}

Samples were assigned to microbiome profile groups (MPGs) based on hierarchical clustering of OTU relative abundances, using Bray-Curtis dissimilarity as the distance metric and complete linkage (implemented in the R function *hclust*). These analyses included all common OTUs (defined as mean relative abundance \>0.1%, present in \>20% of samples, and dominating (\>50%) at least one sample); aggregated counts of other OTUs from each of the major genera (*Moraxella*, *Streptococcus*, *Haemophilus*, *Alloiococcus*, *Corynebacterium*, *Staphylococcus*) and family Moraxellaceae; and a final group consisting of aggregated counts of all other OTUs (labelled 'rare OTUs'; see rows in [Figure 1](#fig1){ref-type="fig"}). The number of clusters (i.e. unique MPGs) was chosen to maximise the median silhouette value. MPGs were named based on the dominant genus or OTU, as indicated in [Table S1](#mmc1){ref-type="supplementary-material"}. Alpha (within-sample) diversity was assessed using Shannon's diversity index measure, which takes into account both number and relative abundance of the OTUs.

### Association of Bacterial OTUs with Symptoms of Acute Respiratory Illness {#sec4.5.2}

We normalized the copy-number-corrected OTU read counts using cumulative sum scaling (CSS) ([@bib35]). Briefly, for each sample, the OTU counts were divided by the cumulative sum of counts up to the smallest percentile for which sample-specific count distributions were largely invariant (98.9^th^ percentile for our data). We then tested for differential abundance in ARI vs healthy samples, for each of 1,090 OTUs that were present in \>10% of samples. A zero inflated Gaussian mixture model was fitted to the log transformed CSS-normalized OTU counts, separately for samples before and after 2 years of age (before 2 years: inclusive of samples at 2-year timepoint; after 2 years: from 2.5-year timepoint), using the R package *metagenomeSeq* ([@bib35]). We summarized the results for OTUs with an absolute fold change of \>1.5 and FDR adjusted p-value \<0.025 in either age strata. We picked eight representative OTUs to more precisely investigate how the associations changed over time, and modelled the longitudinal structure of the data using smoothing splines ANOVA with 100 permutations to assess significance ([@bib36]). All models for the ARI vs. healthy association were adjusted for age, season, gender, and any antibiotics within the last 4 weeks.

### Correlations between Bacterial OTUs {#sec4.5.3}

We inferred correlation networks among the 1,090 common OTUs present in \>10% of samples using FastSpar ([@bib52]), an efficient C++ implementation of the SparCC algorithm, which was designed to deal specifically with compositional data and produces more reliable and robust correlation estimates compared to Pearson or Spearman correlation especially in the case of low diversity samples ([@bib17]). SparCC uses a log ratio transformation and calculates correlations between OTUs in an iterative manner, under the assumption of a sparse network. Statistical significance of the correlation was assessed using 1000 bootstrap samples with exact p-value calculations based on the *permp* function in R package *statmod* ([@bib39]). Correlation networks were generated across all samples, as well as separately for samples before and after 2 years of age, samples within each half yearly time periods, and samples with low abundance (\<1%) of *Moraxella* OTU. We assessed differences in correlation before and after two years using the Fisher's r-to-Z transformation (*cocor* R package).

### Within-Individual Dynamics {#sec4.5.4}

We first explored microbiome changes within each child in terms of transitions from a healthy sample to the next healthy sample half a year or a year later. Transitions which resulted in a MPG change indicated an abrupt shift in the major OTU (termed "unstable transitions"); stable otherwise. We also assessed the transitions using the Bray-Curtis dissimilarity calculated on the CSS-transformed OTU count matrix using the *vegan* R package ([@bib34]), which represented subtle changes. Transition stability and distance were assessed for the effects of intervening ARI, LRI and antibiotics using GEE regression (logistic or linear where appropriate), adjusting for the age of first sample and difference in ages between samples.

We then investigated whether we could detect changes in the NPM prior to ARI symptoms, and how long these changes persisted after the illness. We grouped the healthy samples according to how soon after illness occurred (pre-illness: 1-2 weeks, 2-3 week, 3-4 weeks or \>4 weeks) and how long after the last illness episode (post-illness: 1-2 months, 2-4 months, 4-6 months, 6-12 months, or \>12 months). We used GEE logistic or linear regression to model (i) assignment to specific illness-associated MPGs or (ii) log abundance of specific illness-associated OTUs, against time to ARI/URI/LRI (separately for each pre-illness time category compared to all other healthy samples), and adjusted for time post-illness, gender, age, season, recent antibiotics, and any virus.

Lastly, we examined per child, if the proportion of illness-associated *Moraxella*, *Haemophilus* and *Streptococcus* MPGs in their healthy asymptomatic samples over different time periods (6 months to 2 years, and 2.5 years to 4 years) was associated with LRI frequency and subsequent wheeze phenotypes (wheeze at age 5 years or transient wheeze). Logistic regression was used to model (i) the proportion of illness-associated MPGs (as a binary: ≥50% versus \<50%, excluding children with \<2 healthy samples in each corresponding time period) against LRI and febrile LRI frequency in years 1, 2, 3 and 4, (ii) wheeze phenotypes against proportion of illness-associated MPGs (as tertiles), adjusting for LRI frequency. Separate models were fit for children with and without early allergic sensitization by 2 years of age.

### Statistical Methods {#sec4.5.5}

All statistical analyses were performed using R ([@bib40]) unless otherwise stated. Association analyses that involved multiple samples from the same subject were modelled using generalized estimating equations (GEE) with unstructured correlation and robust standard errors, where possible. In the case of non-convergence due to insufficient sample size, the ordinary logistic regression was used. Potential confounders were included in the model. We used the Benjamini-Hochberg false discovery rate method (FDR) ([@bib2]) or Bonferroni correction where multiple testing p-value adjustments were needed, as stated. All boxplots shown use the Tukey format, in which the bottom and top of the box represents the lower and upper quartiles respectively and the ends of whiskers represents the lowest/highest datum still within 1.5 interquartile range of the lower/upper quartile.

### Definition of Variables Used in Statistical Analyses {#sec4.5.6}

•Wheeze at age 5: Presence of wheeze in the last 12 months recorded in the 5 year questionnaire.•Transient wheeze: Any wheeze in the first three years, but no wheeze in the 5^th^ year.•Early allergic sensitization: Any allergen-specific IgE levels \> 0.35 kU/L by two years of age (at any of 6 month, 1 year or 2 years timepoints).•Season: According to month of collection: spring (September--November), summer (December--February), autumn (March--May) or winter (June--August).•Recent antibiotics: Any record of antibiotics intake within the last 4 weeks prior to sample collection.

### OTU and Microbiome Profile Group (MPG) Distributions and Associated Predicted Species {#sec4.5.7}

The *Moraxella* genus was overwhelmingly represented by OTU 4398454 (*M*. *catarrhalis*) throughout all five years ([Figure S1](#mmc1){ref-type="supplementary-material"}B). The associated *Moraxella* MPG, which was dominated by this OTU, was of relatively low frequency in the 2-month healthy samples (13%), but increased sharply thereafter, stabilizing at an average of 39% from one year of age. In ARI samples, the *Moraxella* MPG followed a similar trend, increasing from 29% at two months of age to ∼43% in the later time periods ([Figure 1](#fig1){ref-type="fig"}B). In addition, 5% of all samples fell into one of two MPGs dominated by OTUs classified to the *Moraxellaceae* family (either OTU 1057260 or 854899); NCBI blastn searches of these sequences matched closely to *Moraxella lincolnii* ([Figure S2](#mmc1){ref-type="supplementary-material"}). This species had been previously isolated from the human respiratory tract (ages 6 months -- adult) ([@bib50]), and was also observed in a 16S analysis of NP samples of children aged 6 months to 2 years in a Dutch population ([@bib3]). In our data, these MPGs were negatively associated with ARI (OR 0.7, p = 0.016; [Table S2](#mmc1){ref-type="supplementary-material"}).

The *Streptococcus* genus was mostly represented by OTU 1059655 (67% of all *Streptococcus* reads; orange in [Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}), whose representative sequence was closest to the *Streptococcus pneumoniae--pseudopneumoniae* complex ([Figure S2](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}). The presence of this OTU in ARI samples in the first year was correlated with detectable IgG1 antibodies to *S*. *pneumoniae* pneumococcal surface protein A1, A2, or C at one year of age as previously reported ([@bib48]). Samples dominated by this OTU clustered into a single MPG we labelled "Streptococcus" (orange in [Figure 1](#fig1){ref-type="fig"}B), which was rarely observed in two-month samples but common thereafter (from 6 months: mean of 5% and 14% in healthy and ARI samples, respectively). The next most frequently observed *Streptococcus* OTU was 1004451 (15%; green in [Figure S1](#mmc1){ref-type="supplementary-material"}); its V4 sequence is distinguished from 1059655 by a common base substitution (tree in [Figure S2](#mmc1){ref-type="supplementary-material"}), and is close to many commensal *Streptococcus* species ([Table S1](#mmc1){ref-type="supplementary-material"}). Samples assigned to the "other Streptococcus" MPG were often dominated by this OTU ([Figure 1](#fig1){ref-type="fig"}A).

The *Haemophilus* genus was represented by two distinct MPGs dominated by OTU 240051 or 956702 ([Figure 1](#fig1){ref-type="fig"}A), both of which show best matches with *H*. *influenzae* and *H*. *haemolyticus* sequences (which are not distinguishable at the V4 region; see [Figure S2](#mmc1){ref-type="supplementary-material"}). As previously reported, the presence of these OTUs in ARI samples in the first year was correlated with detectable IgG1/IgG4 antibodies to *H*. *influenzae* P4/P6 surface proteins at one year of age ([@bib48]). These MPGs were infrequent in the healthy samples (2%), but comprised 11% of ARI samples ([Figure 1](#fig1){ref-type="fig"}B). The rare *Haemophilus* OTUs were also close to *H*. *influenzae* and *H*. *haemolyticus* sequences, with the exception of 4404220, 4053636 and 3605478 which were distant from these but clustered with *H*. *parainfluenzae* and *H*. *parahaemolyticus* ([Figure S2](#mmc1){ref-type="supplementary-material"}) and were occasionally detected in healthy samples ([Figure S1](#mmc1){ref-type="supplementary-material"}).

The *Corynebacterium* genus was primarily represented by OTU 4474764, which best matched the commensal orophangeal bacterium *C*. *propinquum* ([Figure S2](#mmc1){ref-type="supplementary-material"}). A distantly related OTU 4376867 (matching the nasal coloniser *C*. *accolens*) was detected in infancy (16% of *Corynebacterium* reads in the first 6 months) but very rarely thereafter ([Figure S1](#mmc1){ref-type="supplementary-material"}B; all 17 samples assigned to the associated MPG were collected during the first year of life, 15 (88%) of which in the first 6 months, [Figure 1](#fig1){ref-type="fig"}B). Samples dominated (\>29%) by OTU 4474764 (closest to *C*. *propinquum* and *C*. *pseudodiphtheriticum*) clustered into a single MPG we labelled "Corynebacterium", which was frequent in healthy samples in the first 6 months (10-12%), but declined to \<7% thereafter ([Figure 1](#fig1){ref-type="fig"}B). *Corynebacterium* OTU 4474764 frequently co-occurred with *Alloiococcus* (overwhelmingly represented by the *A*. *otidis* / *Dolosigranulum pigrum* OTU 886735), in samples belonging to the *Alloiococcus*-*Corynebacterium* MPG (median 43% *Alloiococcus* OTU 886735 and 32% *Corynebacterium* OTU 4474764).

The *Staphylococcus* genus was mostly represented by OTU 929976, although there were also numerous low-abundance *Staphylococcus* OTUs that co-occurred with this one ([Figure 1](#fig1){ref-type="fig"}A). The *Staphylococcus* MPG (median 43% OTU 929976 and 9% other *Staphylococcus* OTUs) was most common at 2 months (36% and 28% in healthy and ARI samples, respectively) but declined to low levels subsequently in ARI samples (0-11%, [Figure 1](#fig1){ref-type="fig"}B). *Staphylococcus* species are not well resolved at the 16S V4 region; OTU 929976 is identical to known sequences from *S*. *aureus* but also other species ([Figure S2](#mmc1){ref-type="supplementary-material"}).

Data and Software Availability {#sec4.6}
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Sequencing data for this study, cleaned for human reads, has been deposited in the NCBI GenBank (accession SRP056779).
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